Prenatal pharmacotherapy rescues brain development in a Down’s syndrome mouse model
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prenatal pharmacotherapy rescues brain development in a Down’s syndrome mouse model
Authors
Keywords
-
Journal
BRAIN
Volume 137, Issue 2, Pages 380-401
Publisher
Oxford University Press (OUP)
Online
2013-12-13
DOI
10.1093/brain/awt340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of Major Malformations in Infants following Antidepressant Exposure in Pregnancy: Results of a Large Prospective Cohort Study
- (2017) Adrienne Einarson et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome
- (2013) Faycal Guedj et al. PRENATAL DIAGNOSIS
- Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies
- (2012) Rachel M. Hayes et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice
- (2012) Walter Adriani et al. Behavioral and Brain Functions
- Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome
- (2012) Sandra Guidi et al. BRAIN PATHOLOGY
- Embryonic Birthdate of Hypothalamic Leptin-Activated Neurons in Mice
- (2012) Yuko Ishii et al. ENDOCRINOLOGY
- Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor Antagonists
- (2012) A. M. Kleschevnikov et al. JOURNAL OF NEUROSCIENCE
- Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome
- (2012) Xavier Altafaj et al. NEUROBIOLOGY OF DISEASE
- Prenatal Treatment Prevents Learning Deficit in Down Syndrome Model
- (2012) Maddalena Incerti et al. PLoS One
- Adult-Onset Fluoxetine Treatment Does Not Improve Behavioral Impairments and May Have Adverse Effects on the Ts65Dn Mouse Model of Down Syndrome
- (2012) Markus Heinen et al. NEURAL PLASTICITY
- Serotonin 1A receptor-mediated signaling through ERK and PKCα is essential for normal synaptogenesis in neonatal mouse hippocampus
- (2012) A Mogha et al. Translational Psychiatry
- Mouse Models for Down Syndrome-Associated Developmental Cognitive Disabilities
- (2011) Chunhong Liu et al. DEVELOPMENTAL NEUROSCIENCE
- Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn
- (2011) Laura G. Reinholdt et al. MAMMALIAN GENOME
- S100B and APP Promote a Gliocentric Shift and Impaired Neurogenesis in Down Syndrome Neural Progenitors
- (2011) Jie Lu et al. PLoS One
- Antidepressants Stimulate Hippocampal Neurogenesis by Inhibiting p21 Expression in the Subgranular Zone of the Hipppocampus
- (2011) Robert N. Pechnick et al. PLoS One
- Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment
- (2011) Valentine Bouet et al. PSYCHOPHARMACOLOGY
- Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
- (2011) Renata Bartesaghi et al. REVIEWS IN THE NEUROSCIENCES
- Widespread Proliferation Impairment and Hypocellularity in the Cerebellum of Fetuses with Down Syndrome
- (2010) Sandra Guidi et al. BRAIN PATHOLOGY
- Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome
- (2010) Joshua D. Blazek et al. DEVELOPMENTAL DYNAMICS
- Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells
- (2010) Joongkyu Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dynamic spatiotemporal gene expression in embryonic mouse thalamus
- (2010) Asuka Suzuki-Hirano et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome
- (2010) P. Bianchi et al. JOURNAL OF NEUROSCIENCE
- Fetal Exposure to Antidepressants and Normal Milestone Development at 6 and 19 Months of Age
- (2010) L. H. Pedersen et al. PEDIATRICS
- Ventro-Striatal Reductions Underpin Symptoms of Hyperactivity and Impulsivity in Attention-Deficit/Hyperactivity Disorder
- (2009) Susanna Carmona et al. BIOLOGICAL PSYCHIATRY
- Cell Cycle Elongation Impairs Proliferation of Cerebellar Granule Cell Precursors in the Ts65Dn Mouse, an Animal Model for Down Syndrome
- (2008) Andrea Contestabile et al. BRAIN PATHOLOGY
- Mental retardation and associated neurological dysfunctions in Down syndrome: A consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways
- (2008) Mohammed Rachidi et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Chronic Fluoxetine Stimulates Maturation and Synaptic Plasticity of Adult-Born Hippocampal Granule Cells
- (2008) J.-W. Wang et al. JOURNAL OF NEUROSCIENCE
- Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency
- (2008) Stuart J. Warden et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started